Clinical findings and diagnosis in genetic prion diseases in Germany

被引:27
作者
Krasnianski, Anna [1 ,5 ]
Heinemann, Uta [1 ]
Ponto, Claudia [1 ]
Kortt, Jasmine [1 ]
Kallenberg, Kai [2 ]
Varges, Daniela [1 ]
Schulz-Schaeffer, Walter J. [3 ]
Kretzschmar, Hans A. [4 ]
Zerr, Inga [1 ]
机构
[1] Univ Gottingen, Univ Med Sch, Natl Reference Ctr TSE Surveillance, Dept Neurol, Robert Koch Str 40, D-37075 Gottingen, Germany
[2] Univ Gottingen, Univ Med Sch, Dept Neuroradiol, D-37075 Gottingen, Germany
[3] Univ Gottingen, Univ Med Sch, Dept Neuropathol, D-37075 Gottingen, Germany
[4] Univ Munich, Dept Neuropathol, Munich, Germany
[5] Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, D-60054 Frankfurt, Germany
关键词
Prion disease; Familial CJD; M129V polymorphism; PRNP mutation; CREUTZFELDT-JAKOB-DISEASE; FATAL FAMILIAL INSOMNIA; PHENOTYPIC HETEROGENEITY; 14-3-3; PROTEIN; MUTATION; CLASSIFICATION; CRITERIA; CJD;
D O I
10.1007/s10654-015-0049-y
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
To describe the clinical syndrome and diagnostic tests in patients with genetic prion diseases (gPD) in Germany. Clinical features, MRI, EEG, and CSF markers were studied in 91 patients (28 D178N, 20 E200K, 17 inserts, 13 V210I, 8 P102L, 5 E196K). Dementia (35 %) and ataxia (29 %) were the most common initial symptoms and signs. A wide variety and high frequency of neurological/psychiatric symptoms and signs was found during disease course in all patients independently of the type of the mutation. Psychiatric manifestations were frequent (87 %). Neuropsychological abnormalities were observed in 67 %, and aphasia was the most common disturbance (45 %). In E200K, V210I and D178N patients, visual/oculomotor deficits were followed by ataxia early in the disease. Dementia followed by ataxia at onset was common in patients with insert and E196K mutation. P102L patients had isolated ataxia over a longer time period followed by pyramidal signs. Dementia was present only late in the disease course. All clinical routine tests such as MRI, EEG and CSF tests were less sensitive than in sporadic CJD. We provide the first detailed analysis of clinical signs and symptoms in a large group of patients with gPD. Frequency of clinical symptoms and signs was similar in different mutations in a later disease course, but the sequence of occurrence may be of great diagnostic importance. CSF markers were shown to be more sensitive than MRI and EEG.
引用
收藏
页码:187 / 196
页数:10
相关论文
共 50 条
  • [41] Large-scale validation of skin prion seeding activity as a biomarker for diagnosis of prion diseases
    Zhang, Weiguanliu
    Orru, Christina D.
    Foutz, Aaron
    Ding, Mingxuan
    Yuan, Jue
    Shah, Syed Zahid Ali
    Zhang, Jing
    Kotobelli, Keisi
    Gerasimenko, Maria
    Gilliland, Tricia
    Chen, Wei
    Tang, Michelle
    Cohen, Mark
    Safar, Jiri
    Xu, Bin
    Hong, Dao-Jun
    Cui, Li
    Hughson, Andrew G.
    Schonberger, Lawrence B.
    Tatsuoka, Curtis
    Chen, Shu G.
    Greenlee, Justin J.
    Wang, Zerui
    Appleby, Brian S.
    Caughey, Byron
    Zou, Wen-Quan
    [J]. ACTA NEUROPATHOLOGICA, 2024, 147 (01)
  • [42] Multisite Skin Biopsies vs Cerebrospinal Fluid for Prion Seeding Activity in the Diagnosis of Prion Diseases
    Chen, Zhong-yun
    Shi, Qi
    Xiao, Kang
    Kong, Yu
    Liang, Dong-lin
    Wang, Yi-hao
    Min, Rong
    Zhang, Jing
    Wang, Zhen
    Ye, Hong
    Gao, Ran
    Chu, Min
    Nan, Hai-tian
    Jiang, De-ming
    Li, Jun-jie
    Wang, Lin
    Zou, Wen-Quan
    Wu, Li-yong
    Dong, Xiao-ping
    [J]. JAMA NEUROLOGY, 2024,
  • [43] Efficient transmission of human prion diseases to a glycan-free prion protein-expressing host
    Cracco, Laura
    Cali, Ignazio
    Cohen, Mark L.
    Aslam, Rabail
    Notari, Silvio
    Kong, Qingzhong
    Newell, Kathy L.
    Ghetti, Bernardino
    Appleby, Brian S.
    Gambetti, Pierluigi
    [J]. BRAIN, 2024, 147 (04) : 1539 - 1552
  • [44] Prion diseases
    Leemans, Michelle
    [J]. ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2020, 21 (01) : 56 - 59
  • [45] Relationships between Clinicopathological Features and Cerebrospinal Fluid Biomarkers in Japanese Patients with Genetic Prion Diseases
    Higuma, Maya
    Sanjo, Nobuo
    Satoh, Katsuya
    Shiga, Yusei
    Sakai, Kenji
    Nozaki, Ichiro
    Hamaguchi, Tsuyoshi
    Nakamura, Yosikazu
    Kitamoto, Tetsuyuki
    Shirabe, Susumu
    Murayama, Shigeo
    Yamada, Masahito
    Tateishi, Jun
    Mizusawa, Hidehiro
    [J]. PLOS ONE, 2013, 8 (03):
  • [46] Prion diseases
    Leemans, Michelle
    [J]. ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2022, 23 (12) : 807 - 810
  • [47] Genetic counseling for prion disease: Updates and best practices
    Goldman, Jill S.
    Vallabh, Sonia M.
    [J]. GENETICS IN MEDICINE, 2022, 24 (10) : 1993 - 2003
  • [48] Prion Diseases
    Venneti, Sriram
    [J]. CLINICS IN LABORATORY MEDICINE, 2010, 30 (01) : 293 - +
  • [49] Prion diseases
    McKintosh, E
    Tabrizi, SJ
    Collinge, J
    [J]. JOURNAL OF NEUROVIROLOGY, 2003, 9 (02) : 183 - 193
  • [50] Prion diseases
    Leemans, Michelle
    [J]. ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2016, 17 (12) : 641 - 644